News

BEAMER’s Innovative Research on AI-Driven Treatment Adherence Prediction Recognised at International Conference

Published on: 16/08/2023

BEAMER’s Innovative Research on AI-Driven Treatment Adherence Prediction Recognised at International Conference
A conference highlight was the acceptance of BEAMER’s study titled ‘Multi-stakeholder Approach for Designing an AI Model to Predict Treatment Adherence’.

In a remarkable showcase of cutting-edge research and innovation, Beatriz Merino from BEAMER’s Work Package 2 participated in the 25th International Conference on Human-Computer Interaction, hosted at the prestigious AC Bella Sky Hotel and Bella Center.

The conference served as a global platform for sharing advancements in the realm of human-computer interaction. Beatriz represented BEAMER and presented groundbreaking work accomplished within the project.

Her presentation revolved around the outcomes of Work Package 2, a pivotal phase involving the execution of a comprehensive stakeholder strategy. This expertly designed approach aimed to gather essential model requirements, playing a crucial role in shaping the direction of BEAMER’s research. The presentation delved into the intricacies of stakeholder engagement and highlighted results obtained through this collaborative approach.

A conference highlight was the acceptance of BEAMER’s study titled ‘Multi-stakeholder Approach for Designing an AI Model to Predict Treatment Adherence’.

This remarkable achievement underscores BEAMER’s commitment to developing innovative solutions that bridge the gap between technology and healthcare. In this study, semi-structured interviews were conducted with eleven stakeholders from four groups: patients, healthcare professionals, data scientists, and pharmacists. The needs and requirements received were categorised into four key aspects that were translated into requirements and needs: understanding the nature of the drivers, scope, and impact of the problem; identifying data sources; understanding relevant data points; and addressing potential ethical issues.

“We are thrilled to have our work recognized at such a prestigious international forum,” said Beatriz. “This acknowledgement is a testament to the hard work of the entire BEAMER team and the collaborative spirit of our stakeholders.”

Explore the study’s publication here, offering readers an in-depth exploration of the innovative approach and its potential impact on treatment adherence prediction.

NEWS​

Related News

Kuopio Health – The Future is Full of Opportunities

17 Feb 2025
Kuopio Health's year 2024 was a record-breaking year. The ecosystem grew with 13 new members and one new partner. This is the result of the power of c...

InnoHSupport Open Calls

11 Feb 2025
Welcome to the InnoHSupport Open Calls!

Healthcare AI Solutions

6 Feb 2025
The UK government has launched a £150 million procurement drive for artificial intelligence solutions that can be used by the NHS in areas like medica...

Women Entrepreneurship Bootcamp

6 Feb 2025
Welcome to EIT Health Women Entrepreneurship Bootcamp – a customised experience crafted exclusively for you.  

MedTech Bootcamp

6 Feb 2025
EIT Health’s MedTech Bootcamp has been exclusively crafted for trailblazers like you to help you get a clear and valid proof of concept for your idea.

Empowering AI Innovations to Transform Lives: GSMA Launches New Innovation Fund for Startups

6 Feb 2025
The GSMA Innovation Fund is offering grants of up to £250,000 and tailored venture-building support for enterprises using AI and emerging technologies...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *